The cost of losing weight: A personal journey with Wegovy
The journey to weight loss can be a challenging and expensive one, especially when medication is involved. For Valentina Florez-Betancur, a 26-year-old from Wellington, New Zealand, the decision to use Wegovy, a GLP-1 weight-loss drug, was a significant one. With a starting weight of 83kg and a desire to improve her health and future prospects, she embarked on a transformative path.
A Personal Decision
Florez-Betancur's story highlights the personal nature of weight loss journeys. She began her journey during a period of depression, which led to significant weight gain. This weight gain had serious implications for her future plans, including her ability to conceive and maintain a healthy pregnancy. The decision to use Wegovy was a calculated one, considering the potential benefits and the financial burden.
The Cost of Medication
The financial aspect of weight loss medication is a critical factor. Florez-Betancur, on the highest dosage of Wegovy, pays around $469 for a four-week supply. This cost is a significant barrier for many, and she often has to use Afterpay to afford her prescription. The stigma attached to using weight-loss medication is another challenge, with Florez-Betancur noting that discussions about the drug are often difficult within a Facebook group of 15,000 users.
A Transformative Journey
Despite the financial and social challenges, Florez-Betancur's journey with Wegovy has been transformative. She has lost 16kg in six months, a significant achievement. The physical changes are evident, but the impact goes beyond that. Her confidence has improved, and she now has a renewed desire to engage in social activities, such as dates with her husband. The drug has not turned her into a 'health-freak', but rather has helped her develop a healthier relationship with food.
Dietitian's Perspective
The rise of GLP-1 medications has also impacted the work of dietitians. Kylie Russel, a dietitian, notes a shift in her practice. Historically, weight loss focused on reducing calorie intake, but now the emphasis is on ensuring adequate nutrition through key foods like protein, vitamin D, and fibre. This shift is a result of the potential deficiencies that can occur when using these medications.
Conclusion
Florez-Betancur's journey with Wegovy is a personal one, highlighting the challenges and benefits of weight loss medication. The financial burden and social stigma are significant obstacles, but the potential for improved health and well-being can be life-changing. As the use of GLP-1 medications continues to grow, it is essential to address these challenges and provide support for those embarking on similar journeys.
